# Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects

> **NCT01420913** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT01420913
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2011-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420913, "Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01420913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*